Cargando…

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

BACKGROUND: Posttraumatic stress disorder often does not resolve after conventional psychotherapies or pharmacotherapies. Pilot studies have reported that 3,4-methylenedioxymethamphetamine (MDMA) combined with psychotherapy reduces posttraumatic stress disorder symptoms. AIMS: This pilot dose respon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ot’alora G, Marcela, Grigsby, Jim, Poulter, Bruce, Van Derveer, Joseph W, Giron, Sara Gael, Jerome, Lisa, Feduccia, Allison A, Hamilton, Scott, Yazar-Klosinski, Berra, Emerson, Amy, Mithoefer, Michael C, Doblin, Rick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6247454/ https://www.ncbi.nlm.nih.gov/pubmed/30371148 http://dx.doi.org/10.1177/0269881118806297

Ejemplares similares

Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline
por: Feduccia, Allison A., et al.
Publicado: (2019)

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study
por: Mithoefer, Michael C, et al.
Publicado: (2013)

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study
por: Mithoefer, Michael C, et al.
Publicado: (2011)

3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil
por: Jardim, Alvaro V., et al.
Publicado: (2020)

Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials
por: Jerome, Lisa, et al.
Publicado: (2020)

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
por: Mithoefer, Michael C., et al.
Publicado: (2019)

Sleep Quality Improvements After MDMA‐Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder
por: Ponte, Linnae, et al.
Publicado: (2021)

MDMA-facilitated cognitive-behavioural conjoint therapy for posttraumatic stress disorder: an uncontrolled trial
por: Monson, Candice M., et al.
Publicado: (2020)

Posttraumatic Growth After MDMA‐Assisted Psychotherapy for Posttraumatic Stress Disorder
por: Gorman, Ingmar, et al.
Publicado: (2020)

Therapeutic effect of increased openness: Investigating mechanism of action in MDMA-assisted psychotherapy
por: Wagner, Mark T, et al.
Publicado: (2017)

MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study
por: Wolfson, Philip E., et al.
Publicado: (2020)

The cost-effectiveness of MDMA-assisted psychotherapy for the treatment of chronic, treatment-resistant PTSD
por: Marseille, Elliot, et al.
Publicado: (2020)

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
por: Gasser, Peter, et al.
Publicado: (2014)

Methylenedioxymethamphetamine-assisted Psychotherapy For Posttraumatic Stress Disorder: A Review
por: Sá Couto, J., et al.
Publicado: (2022)

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study
por: Danforth, Alicia L., et al.
Publicado: (2018)

Altered brain activity and functional connectivity after MDMA-assisted therapy for post-traumatic stress disorder
por: Singleton, S. Parker, et al.
Publicado: (2023)

A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
por: Sessa, Ben, et al.
Publicado: (2019)

MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial
por: Mitchell, Jennifer M., et al.
Publicado: (2023)

Beyond ecstasy: Alternative entactogens to 3,4-methylenedioxymethamphetamine with potential applications in psychotherapy
por: Oeri, Hans Emanuel
Publicado: (2020)

Potential Psychiatric Uses for MDMA
por: Yazar‐Klosinski, BB, et al.
Publicado: (2017)

Discontinuation of medications classified as reuptake inhibitors affects treatment response of MDMA-assisted psychotherapy
por: Feduccia, Allison A., et al.
Publicado: (2020)

3,4-methylenedioxymethamphetamine (MDMA): current perspectives
por: Meyer, Jerrold S
Publicado: (2013)

MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
por: Mitchell, Jennifer M., et al.
Publicado: (2021)

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning
por: Young, M B, et al.
Publicado: (2015)

Effects of 3,4-Methylenedioxymethamphetamine Administration on Retinal Physiology in the Rat
por: Martins, João, et al.
Publicado: (2011)

Effects of (±) 3,4-Methylenedioxymethamphetamine (MDMA) on Sleep and Circadian Rhythms
por: McCann, Una D., et al.
Publicado: (2007)

The Effects of 3,4-methylenedioxymethamphetamine on Neurogenesis in the Hippocampus of Male Rats
por: Soleimani Asl, Sara, et al.
Publicado: (2020)

The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinical trial
por: Bonn-Miller, Marcel O., et al.
Publicado: (2021)

Neuronal reorganization in adult rats neonatally exposed to (±)-3,4-methylenedioxymethamphetamine
por: Williams, Michael T., et al.
Publicado: (2014)

A review on the mitochondrial toxicity of “ecstasy” (3,4-methylenedioxymethamphetamine, MDMA)
por: Capela, João Paulo, et al.
Publicado: (2022)

Zingiber Officinale Alters 3,4-methylenedioxymethamphetamine-Induced Neurotoxicity in Rat Brain
por: Mehdizadeh, Mehdi, et al.
Publicado: (2012)

Social Cognition and Interaction in Chronic Users of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
por: Wunderli, Michael D, et al.
Publicado: (2017)

The effect of 3,4- methylenedioxymethamphetamine on expression of neurotrophic factors in hippocampus of male rats
por: Soleimani Asl, Sara, et al.
Publicado: (2017)

Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist’s Perspective
por: Sessa, Ben
Publicado: (2017)

3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review
por: Inouye, Ann, et al.
Publicado: (2022)

Therapeutic role of psilocybin and 3,4-methylenedioxymethamphetamine in trauma: A literature review
por: Fonseka, Lakshan N, et al.
Publicado: (2023)

3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
por: Baumann, Michael H., et al.
Publicado: (2006)

The influence of the host microbiome on 3,4-methylenedioxymethamphetamine (MDMA)-induced hyperthermia and vice versa
por: Ridge, Emily A., et al.
Publicado: (2019)

Methylenedioxymethamphetamine-induced toxic valvulopathy
por: Sol, Bastiaan, et al.
Publicado: (2020)

Fully Validated, Multi-Kilogram cGMP Synthesis of MDMA
por: Nair, Jay B., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1brtivrgnlbrdpnqbjd19ehdcc